Literature DB >> 32071397

Cancer-derived UTX TPR mutations G137V and D336G impair interaction with MLL3/4 complexes and affect UTX subcellular localization.

Hiroyuki Kato1,2,3, Kaori Asamitsu4, Wendi Sun5, Shojiro Kitajima5,6, Naoko Yoshizawa-Sugata7, Takashi Okamoto4, Hisao Masai7, Lorenz Poellinger5,8.   

Abstract

The ubiquitously transcribed tetratricopeptide repeat on X chromosome (UTX) is a major histone H3 lysine 27 (H3K27) demethylase and the mixed-lineage leukemia (MLL) proteins are the H3K4 methyltransferases. UTX is one of the major components of MLL3- and MLL4-containing (MlLL3/4) complexes and likely has functions within the complexes. Although UTX is frequently mutated in various types of cancer and is thought to play a crucial role as a tumor suppressor, the importance of UTX interaction with MLL3/4 complexes in cancer formation is poorly understood. Here, we analyzed the ability of cancer-derived UTX mutant proteins to interact with ASH2L, which is a common core component of all the MLL complexes, and MLL3/4-specific components PTIP and PA1, and found that several single-amino acid substitution mutations in the tetratricopeptide repeat (TPR) affect UTX interaction with these components. Interaction-compromised mutants G137V and D336G and a TPR-deleted mutant Δ80-397 were preferentially localized to the cytoplasm, suggesting that UTX is retained in the nucleus by MLL3/4 complexes through their interaction with the TPR. Intriguingly, WT UTX suppressed colony formation in soft agar, whereas G137V failed. This suggests that interaction of UTX with MLL3/4 complex plays a crucial role in their tumor suppressor function. Preferential cytoplasmic localization was also observed for endogenous proteins of G137V and another mutant G137VΔ138 in HCT116 created by CRISPR-Cas9 gene editing. Interestingly, expression levels of these mutants were low and MG312 stabilized both endogenous as well as exogenous G137V proteins. These results reveal a novel mechanism of UTX regulation and reinforce the importance of UTX interaction with MLL3/4 complexes in cancer formation.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32071397     DOI: 10.1038/s41388-020-1218-3

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  59 in total

Review 1.  The tetratricopeptide repeat: a structural motif mediating protein-protein interactions.

Authors:  G L Blatch; M Lässle
Journal:  Bioessays       Date:  1999-11       Impact factor: 4.345

2.  Role of histone H3 lysine 27 methylation in Polycomb-group silencing.

Authors:  Ru Cao; Liangjun Wang; Hengbin Wang; Li Xia; Hediye Erdjument-Bromage; Paul Tempst; Richard S Jones; Yi Zhang
Journal:  Science       Date:  2002-09-26       Impact factor: 47.728

3.  Knockdown of ALR (MLL2) reveals ALR target genes and leads to alterations in cell adhesion and growth.

Authors:  Irina Issaeva; Yulia Zonis; Tanya Rozovskaia; Kira Orlovsky; Carlo M Croce; Tatsuya Nakamura; Alex Mazo; Lea Eisenbach; Eli Canaani
Journal:  Mol Cell Biol       Date:  2006-12-18       Impact factor: 4.272

4.  PTIP associates with MLL3- and MLL4-containing histone H3 lysine 4 methyltransferase complex.

Authors:  Young-Wook Cho; Teresa Hong; Sunhwa Hong; Hong Guo; Hong Yu; Doyeob Kim; Tad Guszczynski; Gregory R Dressler; Terry D Copeland; Markus Kalkum; Kai Ge
Journal:  J Biol Chem       Date:  2007-05-11       Impact factor: 5.157

5.  UTX and JMJD3 are histone H3K27 demethylases involved in HOX gene regulation and development.

Authors:  Karl Agger; Paul A C Cloos; Jesper Christensen; Diego Pasini; Simon Rose; Juri Rappsilber; Irina Issaeva; Eli Canaani; Anna Elisabetta Salcini; Kristian Helin
Journal:  Nature       Date:  2007-08-22       Impact factor: 49.962

6.  A histone H3 lysine 27 demethylase regulates animal posterior development.

Authors:  Fei Lan; Peter E Bayliss; John L Rinn; Johnathan R Whetstine; Jordon K Wang; Shuzhen Chen; Shigeki Iwase; Roman Alpatov; Irina Issaeva; Eli Canaani; Thomas M Roberts; Howard Y Chang; Yang Shi
Journal:  Nature       Date:  2007-09-12       Impact factor: 49.962

7.  Loss of tumor suppressor KDM6A amplifies PRC2-regulated transcriptional repression in bladder cancer and can be targeted through inhibition of EZH2.

Authors:  Lian Dee Ler; Sujoy Ghosh; Xiaoran Chai; Aye Aye Thike; Hong Lee Heng; Ee Yan Siew; Sucharita Dey; Liang Kai Koh; Jing Quan Lim; Weng Khong Lim; Swe Swe Myint; Jia Liang Loh; Pauline Ong; Xin Xiu Sam; Dachuan Huang; Tony Lim; Puay Hoon Tan; Sanjanaa Nagarajan; Christopher Wai Sam Cheng; Henry Ho; Lay Guat Ng; John Yuen; Po-Hung Lin; Cheng-Keng Chuang; Ying-Hsu Chang; Wen-Hui Weng; Steven G Rozen; Patrick Tan; Caretha L Creasy; See-Tong Pang; Michael T McCabe; Song Ling Poon; Bin Tean Teh
Journal:  Sci Transl Med       Date:  2017-02-22       Impact factor: 17.956

8.  Demethylation of H3K27 regulates polycomb recruitment and H2A ubiquitination.

Authors:  Min Gyu Lee; Raffaella Villa; Patrick Trojer; Jessica Norman; Kai-Ping Yan; Danny Reinberg; Luciano Di Croce; Ramin Shiekhattar
Journal:  Science       Date:  2007-08-30       Impact factor: 47.728

9.  The BRCT-domain containing protein PTIP links PAX2 to a histone H3, lysine 4 methyltransferase complex.

Authors:  Sanjeevkumar R Patel; Doyeob Kim; Inna Levitan; Gregory R Dressler
Journal:  Dev Cell       Date:  2007-10       Impact factor: 12.270

10.  Identification of JmjC domain-containing UTX and JMJD3 as histone H3 lysine 27 demethylases.

Authors:  Sunhwa Hong; Young-Wook Cho; Li-Rong Yu; Hong Yu; Timothy D Veenstra; Kai Ge
Journal:  Proc Natl Acad Sci U S A       Date:  2007-11-14       Impact factor: 11.205

View more
  7 in total

Review 1.  PTIP-Associated Protein 1: More Than a Component of the MLL3/4 Complex.

Authors:  Bo Liu; Zhen Li
Journal:  Front Genet       Date:  2022-06-09       Impact factor: 4.772

Review 2.  X- and Y-Linked Chromatin-Modifying Genes as Regulators of Sex-Specific Cancer Incidence and Prognosis.

Authors:  Rossella Tricarico; Emmanuelle Nicolas; Michael J Hall; Erica A Golemis
Journal:  Clin Cancer Res       Date:  2020-07-30       Impact factor: 12.531

Review 3.  Implications of disease-related mutations at protein-protein interfaces.

Authors:  Dapeng Xiong; Dongjin Lee; Le Li; Qiuye Zhao; Haiyuan Yu
Journal:  Curr Opin Struct Biol       Date:  2021-12-24       Impact factor: 6.809

4.  A KDM6 inhibitor potently induces ATF4 and its target gene expression through HRI activation and by UTX inhibition.

Authors:  Shojiro Kitajima; Wendi Sun; Kian Leong Lee; Jolene Caifeng Ho; Seiichi Oyadomari; Takashi Okamoto; Hisao Masai; Lorenz Poellinger; Hiroyuki Kato
Journal:  Sci Rep       Date:  2021-02-25       Impact factor: 4.379

5.  KDM6A mutations promote acute cytoplasmic DNA release, DNA damage response and mitosis defects.

Authors:  J Koch; A Lang; P Whongsiri; W A Schulz; M J Hoffmann; A Greife
Journal:  BMC Mol Cell Biol       Date:  2021-10-26

6.  Decreased Jumonji Domain-Containing 3 at the Promoter Downregulates Hematopoietic Progenitor Kinase 1 Expression and Cytoactivity of T Follicular Helper Cells from Systemic Lupus Erythematosus Patients.

Authors:  Shuaihantian Luo; Yuming Xie; Junke Huang; Juan Liu; Qing Zhang
Journal:  J Immunol Res       Date:  2022-09-28       Impact factor: 4.493

7.  Her2 promotes early dissemination of breast cancer by suppressing the p38 pathway through Skp2-mediated proteasomal degradation of Tpl2.

Authors:  Guanwen Wang; Juan Wang; Antao Chang; Dongmei Cheng; Shan Huang; Dan Wu; Sherona Sirkisoon; Shuang Yang; Hui-Kuan Lin; Hui-Wen Lo; Rong Xiang; Peiqing Sun
Journal:  Oncogene       Date:  2020-09-28       Impact factor: 9.867

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.